1 asset in Idiopathic Mast Cell Activation Syndrome
Therapeutic assets addressing Idiopathic Mast Cell Activation Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
fsd201 Idiopathic Mast Cell Activation Syndrome | Quantum Biopharma | P2 | NR () |